RAD001 Plus Bevacizumab in Metastatic Melanoma

NCT00591734 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Bevacizumab
DRUG: Everolimus

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]